Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
eli lilly
6
×
indiana blog main
indiana top stories
life sciences
merck
6
×
national
6
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
6
×
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
moderna
startups
abbvie
alzheimer's disease
cancer immunotherapy
deals
fda
pfizer
boehringer ingelheim
What
bio
roundup
companies
drug
week
buy
debut
growing
life
moves
nash
news
science
acquisitions
alliance
approval
approved
arena’s
biggest
biogen’s
biopharmaceutical
black
bounty
bristol
build
calls
ceo
changing
cig
color
comeback
company’s
continue
convo
corner
crispr
daniel
days
deals
delivered
Language
unset
Current search:
national
×
" san diego top stories "
×
merck
×
" eli lilly "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More